5 Recruiting Metastatic Pancreatic Cancer Phase 2 Clinical Trials

Active phase 2 studies for metastatic pancreatic cancer enrolling across the USA. Verify eligibility and contact site coordinators.

All Metastatic Pancreatic Cancer studies

Phase 2 Studies for Metastatic Pancreatic Cancer

🔵 Active, Not Recruiting Phase2

Proglumide and Chemotherapy for Metastatic Pancreatic Cancer

📍 Lombardi Comprehensive Cancer Center, Georgetown University — Washington D.C., District of Columbia

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase2

Saltikva for Metastatic Pancreatic Cancer

📍 Segal Cancer Centre/ Mortimer B. Davis-Jewish General Hosptial — Montreal, Quebec

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase2

Redefining FOLFIORINOX in Older Pancreatic Cancer Patients

📍 Fox Chase Cancer Center — Philadelphia, Pennsylvania

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase2

Multi-agent Low Dose Chemotherapy GAX-CI Followed by Olaparib and Pembro in Metastatic Pancreatic Ductal Cancer.

📍 Sidney Kimmel Comprehensive Cancer Center — Baltimore, Maryland

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase2

Study of Combined SGT-53 Plus Gemcitabine/Nab-Paclitaxel for Metastatic Pancreatic Cancer

📍 Mary Crowley Cancer Research Center — Dallas, Texas

View Study & Checklist ➔